Press coverage about Novadaq Technologies (NASDAQ:NVDQ) (TSE:NDQ) has trended somewhat positive on Monday, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Novadaq Technologies earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 44.3968632996132 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of Novadaq Technologies (NVDQ) traded up inf% during trading on Monday, reaching $11.75. 395,280 shares of the company traded hands. The firm has a 50-day moving average price of $11.68 and a 200-day moving average price of $9.03. Novadaq Technologies has a 12 month low of $5.84 and a 12 month high of $12.74. The firm’s market capitalization is $679.41 million.
Several equities analysts recently issued reports on NVDQ shares. First Analysis downgraded shares of Novadaq Technologies from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, June 20th. Royal Bank Of Canada downgraded shares of Novadaq Technologies from an “outperform” rating to a “sector perform” rating and reduced their price objective for the company from $12.00 to $11.75 in a research note on Thursday, July 13th. Canaccord Genuity reissued a “buy” rating and set a $10.00 price objective on shares of Novadaq Technologies in a research note on Monday, June 19th. JMP Securities reissued a “market perform” rating on shares of Novadaq Technologies in a research note on Thursday, July 13th. Finally, Wedbush downgraded shares of Novadaq Technologies from an “outperform” rating to a “neutral” rating in a research note on Monday, June 19th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the stock. Novadaq Technologies currently has a consensus rating of “Hold” and an average price target of $11.86.
TRADEMARK VIOLATION NOTICE: This article was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.chaffeybreeze.com/2017/09/18/novadaq-technologies-nvdq-receiving-somewhat-positive-press-coverage-study-finds.html.
About Novadaq Technologies
NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.
Receive News & Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.